These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23192104)

  • 1. The role of cellular immunity in influenza H1N1 population dynamics.
    Duvvuri VR; Heffernan JM; Moghadas SM; Duvvuri B; Guo H; Fisman DN; Wu J; Wu GE
    BMC Infect Dis; 2012 Nov; 12():329. PubMed ID: 23192104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.
    Wagar LE; Rosella L; Crowcroft N; Lowcock B; Drohomyrecky PC; Foisy J; Gubbay J; Rebbapragada A; Winter AL; Achonu C; Ward BJ; Watts TH
    PLoS One; 2011; 6(11):e28063. PubMed ID: 22132212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.
    Gras S; Kedzierski L; Valkenburg SA; Laurie K; Liu YC; Denholm JT; Richards MJ; Rimmelzwaan GF; Kelso A; Doherty PC; Turner SJ; Rossjohn J; Kedzierska K
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12599-604. PubMed ID: 20616031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.
    Greenbaum JA; Kotturi MF; Kim Y; Oseroff C; Vaughan K; Salimi N; Vita R; Ponomarenko J; Scheuermann RH; Sette A; Peters B
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20365-70. PubMed ID: 19918065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
    Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
    BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
    Rodríguez-Alvarez M; Velasco-Velasco AM; Alvarez-Anell NJ; Jiménez-Corona ME; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):687-92. PubMed ID: 20304258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to seasonal and pandemic influenza A viruses.
    Valkenburg SA; Rutigliano JA; Ellebedy AH; Doherty PC; Thomas PG; Kedzierska K
    Microbes Infect; 2011 May; 13(5):489-501. PubMed ID: 21295153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
    Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
    Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2018 Aug; 36(33):5097-5103. PubMed ID: 30007825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
    Chen LL; Wu WL; Chan WM; Fong CHY; Ng ACK; Ip JD; Lu L; Dissanayake TK; Ding X; Cai JP; Zhang AJX; Tam S; Hung IFN; Chan KH; Yuen KY; To KKW
    Epidemiol Infect; 2019 Sep; 147():e279. PubMed ID: 31556360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.
    Manicassamy B; Medina RA; Hai R; Tsibane T; Stertz S; Nistal-Villán E; Palese P; Basler CF; García-Sastre A
    PLoS Pathog; 2010 Jan; 6(1):e1000745. PubMed ID: 20126449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.
    Wilkinson TM; Li CK; Chui CS; Huang AK; Perkins M; Liebner JC; Lambkin-Williams R; Gilbert A; Oxford J; Nicholas B; Staples KJ; Dong T; Douek DC; McMichael AJ; Xu XN
    Nat Med; 2012 Jan; 18(2):274-80. PubMed ID: 22286307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses.
    Choi A; Ibañez LI; Strohmeier S; Krammer F; García-Sastre A; Schotsaert M
    Front Immunol; 2020; 11():1166. PubMed ID: 32582220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning for the next influenza H1N1 season: a modelling study.
    Carrat F; Pelat C; Levy-Bruhl D; Bonmarin I; Lapidus N
    BMC Infect Dis; 2010 Oct; 10():301. PubMed ID: 20964814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine.
    Joshi SR; Shaw AC; Quagliarello VJ
    Yale J Biol Med; 2009 Dec; 82(4):143-51. PubMed ID: 20027279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses.
    Duvvuri VR; Moghadas SM; Guo H; Duvvuri B; Heffernan JM; Fisman DN; Wu GE; Wu J
    Influenza Other Respir Viruses; 2010 Sep; 4(5):249-58. PubMed ID: 20716156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.